Q32 Bio Inc. (QTTB)
NASDAQ: QTTB · IEX Real-Time Price · USD
26.54
-0.86 (-3.14%)
At close: May 1, 2024, 4:00 PM
26.88
+0.34 (1.28%)
After-hours: May 1, 2024, 7:52 PM EDT
Q32 Bio Revenue
In the year 2023, Q32 Bio had annual revenue of $1.16M, a decrease of -63.97%.
Revenue (ttm)
$1.16M
Revenue Growth
-63.97%
P/S Ratio
273.88
Revenue / Employee
$31,243
Employees
37
Market Cap
316.61M
Revenue Chart
* The company reports in USD currency but revenue data is shown in USD.
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2023 | 1.16M | -2.05M | -63.97% |
Dec 31, 2022 | 3.21M | -30.76M | -90.56% |
Dec 31, 2021 | 33.97M | 31.27M | 1,157.25% |
Dec 31, 2020 | 2.70M | 1.04M | 62.18% |
Dec 31, 2019 | 1.67M | -3.66M | -68.70% |
Dec 31, 2018 | 5.32M | - | - |
Dec 31, 2017 | 0 | - | - |
Dec 31, 2016 | 0 | - | - |
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
ModivCare | 2.76B |
Amarin Corporation | 306.91M |
Esperion Therapeutics | 116.33M |
Caribou Biosciences | 34.48M |
Precigen | 6.23M |
Ocugen | 6.04M |
Sera Prognostics | 306.00K |
QTTB News
- 4 weeks ago - Q32 Bio Appoints Lee Kalowski as President & Chief Financial Officer - PRNewsWire
- 5 weeks ago - Q32 Bio Announces Closing of Merger with Homology Medicines and Concurrent Private Placement of $42 Million - PRNewsWire